healthy subjects
Conditions
Interventions
Group 1: One-time blood collection from all test persons.
Blood sample is tested with 2 test substances: Vaccine with thiomersal and vaccine without thiomersal.
Sponsors
Strathmann GmbH & Co. KG
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: - Currently healthy subject (according to medical history no acute illness, no chronic illness with influence on the immune system). - Suitable vein conditions for blood collection - Tetanus vaccination in the last 10 years (state last tetanus vaccination)
Exclusion criteria
Exclusion criteria: - Vaccination with StroVac - Autoimmune disease - Immunosuppression - Current use of medicines other than anticonceptives
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Currently healthy subject (according to medical history no acute illness, no chronic illness with influence on the immune system). - Suitable vein conditions for blood collection - Tetanus vaccination in the last 10 years (state last tetanus vaccination) | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondarily, it will be investigated whether thiomersal in StroVac has toxic or efficiency-enhancing effects on the lymphocytic immune response in vitro in the LTT. | — |
Countries
Germany
Contacts
Public ContactVolker von Baehr
Institut für Medizinische Diagnostik Berlin-Potsdam GbR (IMD)
Outcome results
None listed